Effects of Stimulation on Immune Cells in Hodgkin's Disease
Author Information
Author(s): Frydecka I, Boćko D, Kosmaczewska A, Ciszak L, Morilla R
Primary Institution: Department of Haematology, Medical University, Pasteura 4, 50367 Wroclław, Poland
Hypothesis
Can low zeta chain expression in Hodgkin's disease be corrected by anti-CD3 and anti-CD3-rIL-2 stimulation?
Conclusion
Stimulation with anti-CD3 and rIL-2 can improve immune cell function in patients with Hodgkin's disease, especially those in remission.
Supporting Evidence
- Zeta chain expression was significantly reduced in unstimulated immune cells from patients with active Hodgkin's disease compared to normal subjects.
- Stimulation with anti-CD3 did not change zeta expression in active disease.
- Co-stimulation with rIL-2 increased the proportion of zeta-expressing CD8+ cells in patients in clinical remission.
Takeaway
This study found that certain treatments can help immune cells work better in people with Hodgkin's disease.
Methodology
Zeta chain expression was analyzed using dual immunofluorescence, and IL-2 levels were measured by ELISA after cell stimulation.
Participant Demographics
Patients with Hodgkin's disease, including those in active disease and complete remission.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website